@FierceMedDev: Chrono Therapeutics snares $32M in Series A money for wearable smoking cessation device. More | Follow @FierceMedDev
@StacyALawrence: Mobile medical app brings laboratory testing to the home. Story | Follow @StacyALawrence
@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: C.R. Bard wins unanimous FDA panel vote for drug-eluting balloon catheter. Article | Follow @EmilyWFierce
> World's tiniest blood glucose monitor launches for iPhone, Android. More
> C.R. Bard ($BCR) announced it will buy back as much as $500 million of its own stock to boost its share price. More
> Want to know if the "Employees Must Wash Hands" sign is actually working? A new wearable monitoring technology can tell you. Some bosses may warmly welcome the Hyginix. Release
> The FDA has extended its comment period on a proposed amendment that would confirm the classification and reclassification of medical devices to certain provisions in the FDASIA. More
Biotech News
@FierceBiotech: This week's Chutes & Ladders: CEO John Johnson jumps ship as Dendreon sinks lower. Report | Follow @FierceBiotech
@JohnCFierce: I have no idea if Porges will be successful, but it's damn good fun to report on it. | Follow @JohnCFierce
@DamianFierce: Break up Amgen Pt. II: Analyst says its moonshot R&D approach is bad for business. Story | Follow @DamianFierce
@EmilyMFierce: Think tank: $4.5B investment in BRAIN Initiative too modest. More | Follow @EmilyMFierce
> With early data looming, Celgene grabs rights to Agios' leukemia drug. Story
> OncoMed hits the brakes on cancer studies after troubling safety signs. News
> Could the cunning use of CVRs save a Pfizer-AstraZeneca merger? Item
Pharma News
@FiercePharma: Vivus hits Actavis with Qsymia patent-infringement lawsuit. Story | Follow @FiercePharma
@TracyStaton: Trending at FiercePharmaMarketing: Do reps push drugs off-label? Study says yes. Does it work? Also yes. More | Follow @TracyStaton
@EricPFierce: Biolyse is back in production with paclitaxel after a re-inspection by Health Canada cleared its plant. News | Follow @EricPFierce
@CarlyHFierce: With patent extension up for grabs, Shire agrees to test Vyvanse in preschoolers. More | Follow @CarlyHFierce
@JustinHFierce: New Pet Pace med device monitors temp and vitals, marketed for owners and vets like an e-dog-whisperer. Article | Follow @JustinHFierce
> U.K. price watchdog weighs in on BMS melanoma blockbuster Yervoy. More
> Roche and Cipla are ordered to mediate in a new twist on Indian IP fights. Story
> Chinese companies ready to pump out generic Viagra as patent expires. Item